Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.419
-0.101 (-19.41%)
At close: Oct 8, 2024, 4:00 PM
0.440
+0.021 (4.99%)
After-hours: Oct 8, 2024, 6:52 PM EDT
Entero Therapeutics Employees
Entero Therapeutics had 9 employees as of December 31, 2023. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
n/a
Profits / Employee
-$715,952
Market Cap
1.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Helius Medical Technologies | 22 |
| Tenon Medical | 21 |
| Bio-Path Holdings | 10 |
| SCWorx | 9 |
| Dermata Therapeutics | 8 |
| Quoin Pharmaceuticals | 4 |
| IMAC Holdings | 4 |
| 60 Degrees Pharmaceuticals | 3 |
ENTO News
- 15 hours ago - Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board - Business Wire
- 6 weeks ago - Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q - GlobeNewsWire
- 2 months ago - Entero Therapeutics' Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - GlobeNewsWire
- 3 months ago - Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease - GlobeNewsWire
- 4 months ago - Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention - GlobeNewsWire
- 5 months ago - Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference - GlobeNewsWire